50 years of developing global health leaders

50 years of developing global health leaders

Up next

Dialogues: a conversation with Peter Hotez

 “Dialogues” is a series from the Global Health Matters podcast where we bring you interviews featuring fresh perspectives on global health issues. The goal of each Dialogues episode is to break through the echo chambers that exist in global health through in-depth, t ...

  Show more

Can we eliminate malaria? Perspectives from two women leaders

Significant progress has been made towards a malaria-free world. Forty-three countries have successfully eliminated malaria, with Cabo Verde becoming the third African country declared malaria-free earlier this year. Africa, however, still continues to experience the highest s ...

  Show more

Recommended Episodes

Introduction to Global Health
The Rx Bricks Podcast

<h2 id="header-9c83a0c4947a4ff482f264ddb56bfda5" class="brick-header brick-header-primary markup-enabled medium-editor-element" role="textbox" data-rxannotationdata="content.text" data-medium-editor-element="true" aria-multiline="true" data-medium-editor-editor-index="1" data-pla ...  Show more

Let's Diagnose Global Health Today | Dr Slim Slama
The afikra Podcast

The CEO of the World Innovation Summit for Health (WISH), Dr Slim Slama, joins us on this episode of The afikra Podcast to give an in-depth look into the complexities and challenges facing global health today, including the rise of non-communicable diseases, the impact of urba ...

  Show more

Youth skills in a rapidly changing world
Our World, Connected

Meet Dr John Mugo and Beria Wawira – two colleagues on a mission to empower millions of young people and parents through the Zizi Afrique Foundation in Kenya. In conversation with host Christine Wilson, they ask: are we preparing young people for success in today’s fast-paced ...

  Show more

#22 Reforming pharmacovigilance education – Michael Reumerman
Drug Safety Matters

Send a text message to the show!Healthcare professionals are key players in medicines safety but they often lack the time or knowledge to report adverse drug reactions. To change that, we need to urgently rethink how we teach pharmacovigilance, argues Michael Reumerman from Amste ...  Show more